OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma.

PubMed

Year: 1999
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: F Wang, E Bade, C Kuniyoshi, L Spears, G Jeffery, V Marty, S Groshen, J Weber
Institutions: University of Southern California, USC Norris Comprehensive Cancer Center
Language: English

Topic: Immunotherapy and Immune Responses
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: melanoma, peptide vaccine, Melan-A, incomplete Freund's adjuvant, skin testing, IFN-gamma release, ELISPOT, relapse-free survival, immunodominant peptides, adjuvant immunotherapy
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Award: University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG)
OpenAlex ID: W2162057142
FWCI: 5.673
Cites: 67
Cited by: 242
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms